24 HOUR WU ALLOCATION
| Research | Percent |
|---|---|
|
ALZHEIMERS |
37.21% |
|
ENZYME DYNAMICS |
30.23% |
|
PEPTIDOMIMETIC CD40L BINDING |
23.26% |
|
CANCER |
9.3% |
7 DAY WU ALLOCATION
| Research | Percent |
|---|---|
|
ALZHEIMERS |
58.67% |
|
ENZYME DYNAMICS |
15.82% |
|
PEPTIDOMIMETIC CD40L BINDING |
13.27% |
|
CANCER |
11.22% |
|
PLANT LIPID MUTANT SCREENING |
1.02% |
12 WEEK WU ALLOCATION
| Research | Percent |
|---|---|
|
ALZHEIMERS |
63.3% |
|
ENZYME DYNAMICS |
14.56% |
|
ATGPA1 POST TRANSLATIONAL MODIFICATIONS |
8.45% |
|
PEPTIDOMIMETIC CD40L BINDING |
4.33% |
|
CANCER |
4.16% |
|
ATSTP10 SUCROSE TRANSPORT |
1.34% |
|
PLANT LIPID BIOSYNTHESIS MUTANTS |
1.21% |
|
RCA TEMPERATURE SIMULATIONS |
.95% |
|
ATSTP10 TRANSPORT SIMULATION |
.52% |
|
ATWRI1 MUTANT SCREENING |
.52% |
|
ATGPA1 POST TRANSLATIONAL MODIFICATION DYNAMICS |
.35% |
|
MEMBRANE TRANSPORT |
.22% |
|
PLANT LIPID MUTANT SCREENING |
.09% |